New trends in the management of postpartum haemorrhage

Southern African Journal of Anaesthesia and Analgesia

Volumn 20, Issue 1, 2014, Pages 44-47

  Dyer, R A ^a   Vorster, A D ^a   Arcache, M J ^a   Vasco, M ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b Clinica Reina Sofia   (Colombia)

Author keywords

Management; New trends; Postpartum haemorrhage

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; FIBRINOGEN; FRESH FROZEN PLASMA; HEMOGLOBIN; PLASMINOGEN; THROMBIN; THROMBOPLASTIN; TRANEXAMIC ACID;

BLOOD TRANSFUSION; CESAREAN SECTION; CRYOPRECIPITATE; EPISIOTOMY; FIBRINOLYSIS; HEMATOCRIT; HUMAN; HYSTERECTOMY; NOTE; PLACENTA PREVIA; POSTPARTUM HEMORRHAGE; PREECLAMPSIA; RISK; SOLUTIO PLACENTAE; THROMBOELASTOGRAPHY; URINARY TRACT INJURY; UTERINE ATONY; WORLD HEALTH ORGANIZATION;

EID: 84896454275     PISSN: 22201181     EISSN: None     Source Type: Journal    
DOI: 10.1080/22201173.2014.10844564     Document Type: Note

References (37)

1. Dyer RA, Reed AR, James MF. Obstetric anaesthesia in low-resource settings. Best Pract Res Clin Obstet Gynaecol. 2010;24(3):401-412.
2. Solomon C, Collis RE, Collins PW. Haemostatic monitoring during postpartum haemorrhage and implications for management. Br J Anaesth. 2012;109(6):851-863.
3. Usta IM, Hobeika EM, Musa AA, et al. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. 2005;193(3 Pt 2):1045-1049.
4. Grobman WA, Gersnoviez R, Landon MB, et al. Pregnancy outcomes for women with placenta previa in relation to the number of prior cesarean deliveries. Obstet Gynecol. 2007;110(6):1249-1255.
5. Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011;51(12):2627-2633.
6. Beilin Y, Halpern SH. Placenta accrete: successful outcome is all in the planning. Int J Obstet Anesth. 2013;22(4):269-271.
7. Weiniger CF, Einav S, Deutsch L, et al. Outcomes of prospectivelycollected consecutive cases of antenatal-suspected placenta accreta. Int J Obstet Anesth. 2013;22(4):273-279.
8. Ahonen J, Stefanovic V, Lassila R. Management of post-partum haemorrhage. Acta Anaesthesiol Scand. 2010;54(10):1164-1178.
9. Pacagnella RC, Souza JP, Durocher J et al. A systematic review of the relationship between blood loss and clinical signs. PLoS One. 2013;8(3):e57594.
10. Toledo P, McCarthy RJ, Hewlett BJ, et al. The accuracy of blood loss estimation after simulated vaginal delivery. Anesth Analg. 2007;105(6):1736-1740.
11. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG. 2006;113(8):919-924.
12. Butwick A, Hilton G, Carvalho B. Non-invasive haemoglobin measurement in patients undergoing elective Caesarean section. Br J Anaesth. 2012;108(2):271-277.
13. Skelton VA, Wijayasinghe N, Sharafudeen S, et al. Evaluation of point-of-care haemoglobin measuring devices: a comparison of Radical-7 pulse co-oximetry, HemoCue® and laboratory haemoglobin measurements in obstetric patients. Anaesthesia. 2013;68(1):40-45.
14. De Lloyd L, Bovington R, Kaye A, et al. Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth. 2011;20(2):135-141.
15. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Pract Res Clin Anaesthesiol. 2010;24(1):27-40.
16. Polak F, Kolnikova I, Lips M, et al. New recommendations for thromboelastography reference ranges for pregnant women. Thromb Res. 2011;128(4):e14-e17.
17. Armstrong S, Fernando R, Ashpole K, et al. Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. Int J Obstet Anesth. 2011;20(4):293-298.
18. Huissoud C, Carrabin N, Audibert F, et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG. 2009;116(8):1097-1102.
19. Urwyler N, Theiler L, Hirschberg M, et al. Standard vs. point-of-care measurement of fibrinogen: potential impact on clinical decisions. Minerva Anestesiol. 2012;78(5):550-555.
20. Stocks G. Monitoring transfusion requirements in major obstetric haemorrhage: out with the old and in with the new? Int J Obstet Anesth. 2011;20(4):275-278.
21. Clark SL, Hankins GD. Preventing maternal death: 10 clinical diamonds. Obstet Gynecol. 2012;119(2 Pt 1):360-364.
22. Pacheco LD, Saade GR, Gei AF, Hankins GD. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol. 2011;205(6):526-532.
23. Gutierrez MC, Goodnough LT, Druzin M, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int J Obstet Anesth. 2012;21(3):230-235.
24. Charbit B, Mandelbrot L, Samain E. et al. The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost. 2007;5(2):266-273.
25. Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic assessment of coagulation abnormalities in obstetric patients: usefulness, timing and clinical implications. Br J Anaesth. 1997;78(6):678-683.
26. Peyvandi F, Biguzzi E, Franchi F, et al. Elevated prepartum fibrinogen levels are not associated with a reduced risk of postpartum hemorrhage. J Thromb Haemost. 2012;10(7):1451-1453.
27. Cortet M, Deneux-Tharaux C, Dupont C, et al. Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. Br J Anaesth. 2012;108(6):984-989.
28. Wikkelsoe AJ, Afshari A, Stensballe J, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2012;13:110.
29. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels: the past, present and future. Int J Obstet Anesth. 2013;22(2):87-91.
30. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit Care. 2011;15(2):R117.
31. Gungorduk K, Yildirim G, Asicioglu O, et al. Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. Am J Perinatol. 2011;28(3):233-240.
32. Shakur H, Elbourne D, Gulmezoglu M, et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials. 2010;11:40.
33. Ahonen J. The role of recombinant activated factor VII in obstetric hemorrhage. Curr Opin Anaesthesiol. 2012;25(3):309-314.
34. Mercier FJ, Bonnet MP. Use of clotting factors and other prohemostatic drugs for obstetric hemorrhage. Curr Opin Anaesthesiol. 2010;23(3):310-316.
35. Welsh A, McLintock C, Gatt S, et al. Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage. Aust NZ J Obstet Gynaecol. 2008;48(1):12-16.
36. McCarthy GC, Allen TK, Habib AS. Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage. J Clin Anesth. 2012;24(6):508-509.
37. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth. 2008;17(1):37-45.